Marek Chawarski, PhD

Associate Professor of Psychiatry and of Emergency Medicine

Research Departments & Organizations

Psychiatry: Connecticut Mental Health Center | Division of Addictions | Psychology Section

Yale Institute for Global Health

Office of Cooperative Research

Research Interests

Amphetamine-Related Disorders; China; Malaysia; Opioid-Related Disorders; Psychiatry; Risk-Taking; Russia; Substance Abuse Detection

Activities

  • Teaching and mentoring Changsha, China (2015)

    Honorary Guest Professorship

  • Substance abuse treatment Wuhan, China (2010 - 2017)

    A study entitled "Behavioral Drug and HIV Risk Reduction Counseling with MMT in China" will provide critical data regarding the efficacy for reducing drug-and sex-related HIV transmission risk behaviors, as well as improving MMT outcomes and patient functioning of two transportable counseling...

  • Teaching and research collaboration Taipei, Taiwan (2010)

  • Substance abuse treatment Saint Petersburg, Russia (2010 - 2017)

    A study entitled "Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia" will examine the effects of combining behavioral therapy with naltrexone pharmacotherapy for the treatment of opiate dependence and reduction of HIV risks in opiate dependent individuals in St. Petersburg,...

  • Research and training collaboration in substance abuse treatment with Universiti Sains Malaysia George Town, Malaysia; Kota Bharu, Malaysia (2010)

    Collaborative research and training programs aimed to develop treatments for opiate and amphetamine type stimulants disorders

  • Teaching and mentoring George Town, Malaysia (2009)

    Adjunct faculty at the Drug Research Centre, University Sains Malaysia (USM)

  • Research and training collaboration Jakarta, Indonesia (2009)

  • Heroin Dependence Tehran, Iran; Muar, Malaysia (2008 - 2017)

    Professor Schottenfeld has established research projects in Malaysia and Iran which are aimed at evaluating treatments for heroin or other opiate dependence and are comparing the efficacy of maintenance treatment with buprenorphine or naltrexone.

  • Prevention of HIV Infection among Opiate Dependent Injectors - Phase III Randomized Controlled Trial to Evaluate the Efficacy of buprenorphine/naloxone drug treatment in p Beijing, China; Chiang Mai, Thailand; Nanning, China; Urumqi, China (2008 - 2015)

    The purpose of the study is to determine the efficacy of a drug treatment intervention (buprenorphine/naloxone) in the prevention of HIV transmission among opiate dependent injectors by reducing drug use and associated risk behaviors. URL: http://www.hptn.org/research_studies/hptn058.asp

Selected Publications

See list of PubMed publications

Edit this profile